Effects of the COVID-19 Pandemic on Anti-vascular Endothelial Growth Factor Treatment in China
We evaluated the impact of the COVID-19 pandemic on anti-VEGF treatment in ophthalmology patients in a single hospital in northern China. A total of 93 anti-VEGF injections were administered to 85 eyes of 72 patients at The China Medical University First Hospital Department of Ophthalmology during t...
Main Authors: | Kai-Bo Yang, Hao Feng, Han Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2020.576275/full |
Similar Items
-
Association of treatment adherence with real-life VA outcomes in AMD, DME, and BRVO patients
by: Ehlken C, et al.
Published: (2017-12-01) -
Real-World Data: Ranibizumab Treatment For Retinal Vein Occlusion In The OCEAN Study
by: Callizo J, et al.
Published: (2019-11-01) -
Profile of patients receiving intravitreal anti-vascular endothelial growth factor injections during COVID-19-related lockdown
by: Manavi D Sindal, et al.
Published: (2021-01-01) -
Intravitreal injection of anti-vascular endothelial growth factor agents for ocular vascular diseases: Clinical practice guideline
by: Homayoun Nikkhah, et al.
Published: (2018-01-01) -
Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy – a systematic approach to identify and characterize data sources
by: Vincent Daien, et al.
Published: (2019-10-01)